PSEUDOEPHEDRINE HYD

The Defense Logistics Agency awarded a single-line delivery order, SPE2DP26F7632, to DMS Pharmaceutical Group Inc. (CAGE 1UNB0) on July 14, 2026, under the basic contract SPE2DX25D9900, for the purchase of 35 packages of Pseudoephedrine Hydrochloride (NSN 6505001490098) at a unit price of $0.8700, totaling $30.45. The product is to be delivered FOB destination to Fort Bragg, North Carolina, by July 29, 2026, with the contractor responsible for all transportation costs and risks until receipt by the government at the delivery site. Inspection and acceptance will occur at the destination by the government’s authorized representative. The awardee is certified as a small business, small disadvantaged business, and women-owned small business, triggering federal reporting obligations under FAR and SBA regulations. Packaging must be traceable, with parcel post prohibited, and all shipments must be marked with the contract identification numbers and product codes such as W50YF261940002 and NDC00536-3607-35, though no specific MIL-STD packaging standards are cited. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, using the accounting code BX: 97X4930 5CBX 001 2620 S33189. The contracting officer, Lisa Quinn, is listed with contact information, but no contracting officer’s representative or technical representative is named. The order reflects a lowest price technically acceptable procurement with no variance allowed in quantity and no options, extensions, or special requirements identified. No formal clause text or DFARS/FAR provisions are explicitly listed, and no attachments or evaluation factors are provided, indicating a streamlined administrative delivery order consistent with routine pharmaceutical procurement under a broad indefinite-delivery vehicle.